サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1266698

細胞溶解/細胞分画の世界市場：動向、機会、競合分析

Cell Lysis & Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-20
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

細胞溶解/細胞分画の世界市場：動向、機会、競合分析
出版日: 2023年04月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の細胞溶解/細胞分画の市場規模は、2023年から2028年までの間に8.3%のCAGRで成長し、2028年までに推定53億米ドルに達すると予想されています。市場の成長を後押しする主な要因には、感染症数の急増、ゲノミクスとプロテオミクスの研究に対する政府資金の増加、個別化医療への注目度の高まりなどが挙げられます。

当レポートでは、世界の細胞溶解/細胞分画市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・課題、製品別・細胞タイプ別・用途別・最終用途産業別・地域別などの分析、さらに競合分析などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の細胞溶解/細胞分画市場：市場力学

  • イントロダクション、背景、および分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析（2017年～2028年）

  • マクロ経済の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界の細胞溶解/細胞分画市場の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界の細胞溶解/細胞分画市場：製品別
    • 消耗品
      • キット・試薬
    • 機器
      • ソニケーター
      • ホモジナイザー
      • その他
  • 世界の細胞溶解/細胞分画市場：細胞タイプ別
    • 哺乳類細胞
    • 微生物細胞
    • その他
  • 世界の細胞溶解/細胞分画市場：用途別
    • タンパク質の精製・分離
    • 核酸の分離・精製
    • その他
  • 世界の細胞溶解/細胞分画市場：最終用途産業別
    • 研究ラボ・機関
    • バイオ医薬品・バイオテクノロジー企業
    • その他

第4章 市場動向と予測分析：地域別（2017年～2028年）

  • 世界の細胞溶解/細胞分画市場、地域別
  • 北米の細胞溶解/細胞分画市場
    • 北米の細胞溶解/細胞分画市場、細胞タイプ別：哺乳類細胞、微生物細胞、その他
    • 北米の細胞溶解/細胞分画市場、最終用途産業別：研究ラボ・機関、バイオ医薬品・バイオテクノロジー企業、その他
  • 欧州の細胞溶解/細胞分画市場
    • 欧州の細胞溶解/細胞分画市場、細胞タイプ別：哺乳類細胞、微生物細胞、その他
    • 欧州の細胞溶解/細胞分画市場、最終用途産業別：研究ラボ・機関、バイオ医薬品・バイオテクノロジー企業、その他
  • アジア太平洋の細胞溶解/細胞分画市場
    • アジア太平洋の細胞溶解/細胞分画市場、細胞タイプ別：哺乳類細胞、微生物細胞、その他
    • アジア太平洋の細胞溶解/細胞分画市場、最終用途産業別：研究ラボ・機関、バイオ医薬品・バイオテクノロジー企業、その他
  • その他地域の細胞溶解/細胞分画市場
    • その他地域の細胞溶解/細胞分画市場、細胞タイプ別：哺乳類細胞、微生物細胞、その他
    • その他地域の細胞溶解/細胞分画市場、最終用途産業別：研究ラボ・機関、バイオ医薬品・バイオテクノロジー企業、その他

第5章 競合分析

  • タイプポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界の細胞溶解/細胞分画市場の成長機会：製品別
    • 世界の細胞溶解/細胞分画市場の成長機会：細胞タイプ別
    • 世界の細胞溶解/細胞分画市場の成長機会：用途別
    • 世界の細胞溶解/細胞分画市場の成長機会：最終用途産業別
    • 世界の細胞溶解/細胞分画市場の成長機会：地域別
  • 世界の細胞溶解/細胞分画市場における新たな動向
  • 戦略分析
    • 新製品の開発
    • 世界の細胞溶解/細胞分画市場のキャパシティ拡大
    • 世界の細胞溶解/細胞分画市場における合併、買収、および合弁事業
    • 認定とライセンシング

第7章 主要企業の企業プロファイル

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson
目次

Cell Lysis & Fractionation Market Trends and Forecast

The future of the global cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies. The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028 with a CAGR of 8.3% from 2023 to 2028. The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Cell Lysis & Fractionation Market by Segment

The study includes trends and forecast for the global cell lysis & fractionation market by product, cell type, application, end use industry, and region, as follows:

Cell Lysis & Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Consumables
    • Kits and Reagents
  • Enzymes
  • Detergent Solutions
  • Others
  • Instruments
    • Sonicators
    • Homogenizers
    • Other Instruments

Cell Lysis & Fractionation Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Mammalian Cells
  • Microbial Cells
  • Others

Cell Lysis & Fractionation Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Protein Purification and Isolation
  • Nucleic Acid Isolation and Purification
  • Others

Cell Lysis & Fractionation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Research Laboratories and Institutes
  • Biopharmaceutical and Biotechnology Companies
  • Others

Cell Lysis & Fractionation Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cell Lysis & Fractionation Companies

Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, cell lysis & fractionation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the cell lysis & fractionation companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson

Cell Lysis & Fractionation Market Insights

  • Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.
  • Research laboratories and institutes are expected to witness the highest growth over the forecast period due to increasing incidence of chronic disease and rising government investment for research.
  • North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.

Features of the Cell Lysis & Fractionation Market

  • Market Size Estimates: Cell lysis & fractionation market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Cell lysis & fractionation market size by various segments, such as product, cell type, application, end use industry, and region
  • Regional Analysis: Cell lysis & fractionation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different types, product, cell type, application, end use industry, and regions for the cell lysis & fractionation market.
  • Strategic Analysis: This includes M&A, new type development, and competitive landscape for the cell lysis & fractionation market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cell lysis & fractionation market size?

Answer: The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028.

Q2. What is the growth forecast for cell lysis & fractionation market?

Answer: The global cell lysis & fractionation market is expected to grow with a CAGR of 8.3% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the cell lysis & fractionation market?

Answer:The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.

Q4. What are the major segments for cell lysis & fractionation market?

Answer: The future of the cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies.

Q5. Who are the key cell lysis & fractionation companies?

Answer: Some of the key cell lysis & fractionation companies are as follows:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson

Q6. Which cell lysis & fractionation segment will be the largest in future?

Answer:Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.

Q7. In cell lysis & fractionation market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the global cell lysis & fractionation market by product ((consumables( kits and reagents (enzymes, detergent solutions, and others)), instruments (sonicators, homogenizers, and other instruments)), cell type (mammalian cells, microbial cells, and other cells), application (protein purification and isolation, nucleic acid isolation and purification, and others), end use industry (research laboratories and institutes, biopharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cell lysis & fractionation Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Cell Lysis & Fractionation Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Cell Lysis & Fractionation Market by Product
    • 3.3.1: Consumables
      • 3.3.1.1: Kits and Reagents
        • 3.3.1.1.1: Enzymes
        • 3.3.1.1.2: Detergent Solutions
        • 3.3.1.1.3: Others
    • 3.3.2: Instruments
      • 3.3.2.1: Sonicators
      • 3.3.2.2: Homogenizers
      • 3.3.2.3.: Other Instruments
  • 3.4: Global Cell Lysis & Fractionation Market by Cell Type
    • 3.4.1: Mammalian Cells
    • 3.4.2: Microbial Cells
    • 3.4.3: Others
  • 3.5: Global Cell Lysis & Fractionation Market by Application
    • 3.5.1: Protein Purification and Isolation
    • 3.5.2: Nucleic Acid Isolation and Purification
    • 3.5.3: Others
  • 3.6: Global Cell Lysis & Fractionation Market by End Use Industry
    • 3.6.1: Research Laboratories and Institutes
    • 3.6.2: Biopharmaceutical and Biotechnology Companies
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Cell Lysis & Fractionation Market by Region
  • 4.2: North American Cell Lysis & Fractionation Market
    • 4.2.1: North American Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.2.2: North American Cell Lysis & Fractionation Market by End Use Industry : Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.3: European Cell Lysis & Fractionation Market
    • 4.3.1: European Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.3.2: European Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.4: APAC Cell Lysis & Fractionation Market
    • 4.4.1: APAC Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.4.2: APAC Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.5: ROW Cell Lysis & Fractionation Market
    • 4.5.1: ROW Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.5.2: ROW Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Type Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Product
    • 6.1.2: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Cell Type
    • 6.1.3: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Application
    • 6.1.4: Growth Opportunities for the Global Cell Lysis & Fractionation Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Region
  • 6.2: Emerging Trends in the Global Cell Lysis & Fractionation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cell Lysis & Fractionation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Lysis & Fractionation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck KGaA
  • 7.3: Bio-Rad Laboratories
  • 7.4: Miltenyi Biotec
  • 7.5: Becton Dickinson